FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Transfusionsmedizin und Cell-Engineering
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Surgery
Department of Transfusion Medicine and Haemostaseology
Overview
Publications
(64)
Research Grants
(1)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
CD40 blockade hampers IgG class-switch while enhancing Granzyme B production by transitional B cells (2025)
Werner F, Wittner J, Lehmann C, Wahlbuhl-Becker M, Allabauer I, Hoffmann A, Schnell A, et al.
Journal article
Rapid clinical effects of convalescent plasma therapy in severe COVID-19 acute respiratory distress syndrome (ARDS) (2025)
Bihlmaier K, Willam C, Herbst L, Hackstein H, Schiffer M
Journal article
Extracorporeal photopheresis reduces the T cell stimulatory capacity of human primary blood conventional dendritic cells type 1 (2025)
Heger L, Berking C, Hackstein H
Journal article
Antithrombotic treatment for cardiological interventions in patients with thrombocytopenia in oncological diseases: Consensus paper of the Working Group on Cardiovascular Hemostasis and Antithrombotic Treatment (AG19) of the German Cardiac Society (DGK), the German Society for Transfusion Medicine and Immunohematology (DGTI), the German Society for Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Haemostasis Research (GTH) Antithrombotische Therapie für kardiologische Eingriffe bei Patienten mit Thrombozytopenie bei onkologischen Erkrankungen: Konsensuspapier der Arbeitsgruppe „Kardiovaskuläre Hämostase und antithrombotische Therapie“ (AG19) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK), der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e. V. (DGTI), der Deutschen Gesellschaft für Hämatologie und Medizinische Onkologie e. V. (DGHO) und der Gesellschaft für Thrombose und Hämostaseforschung e. V. (GTH) (2025)
Naguib D, Bakchoul T, Dietrich S, Geisler T, Hackstein H, Kille A, Koschmieder S, et al.
Journal article
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study (2024)
Beckmann M, Schlüter J, Erdmann M, Kramer R, Cunningham S, Hackstein H, Zimmermann R, Heinzerling L
Journal article
Influence of the Immune Checkpoint Inhibitors on the Hemostatic Potential of Blood Plasma (2024)
Patalakh I, Wandersee A, Schlüter J, Erdmann M, Hackstein H, Cunningham S
Journal article, Original article
Functional Heterogeneity of Umbilical Cord Blood Monocyte-Derived Dendritic Cells (2024)
Schweiger P, Hamann L, Strobel J, Weisbach V, Wandersee A, Christ J, Kehl S, et al.
Journal article
HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activation. (2024)
Welters C, Welters ML, Stadler S, Bullinger L, Strobel J, Hackstein H, Dhamodaran A, et al.
Journal article
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency (2024)
Ruf M, Cunningham S, Wandersee A, Brox R, Achenbach S, Strobel J, Hackstein H, Schneider S
Journal article, Original article
The Protein S Erlangen Mutation PROS1c.1904T>C (F635S) Suppresses Secretion. (2024)
Reißig J, Cunningham S, Wandersee A, Brox R, Achenbach S, Strobel J, Hackstein H, Schneider S
Journal article, Original article
‹
1
2
3
...
7
›